other factors which might increase the risk of haemorrhagic cystitis due to cyclophosphamide administration include the prior administration of busulphan to patients with chronic granulocytic leukaemia , in whom the incidence of haemorrhagic cystitis was 36 % compared with 4 % in all other patients .
C0006463
busulphan
C0023473
chronic granulocytic